ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma

Ma, Zuyi; Li, Zhenchong; Wang, Shujie; Zhou, Qi; Ma, Zuguang; Liu, Chunsheng; Huang, Bowen; Zheng, Zehao; Yang, LinLing; Zou, Yiping; Zhang, Chuanzhao; Huang, Shanzhou*; Hou, Baohua*广东省人民医院; 广州医学院; 南方医科大学; 汕头大学; 中国医学科学院; 中山大学; 中国医学科学院北京协和医院; 1
Journal of Hepatocellular Carcinoma2021DOI: 10.2147/JHC.S320326
9被引8阅读
引用收藏
分享

摘要

Background: Recent evidence has shown that Solute Carrier Family 39 Member 10 (SLC39A10) promoted tumor progression in several cancer types. The study intended to explore the expression and function of SLC39A10 in hepatocellular carcinoma (HCC). @@@ Methods: Multiple bioinformatics analyses were used to evaluate SLC39A10 expression and potential role in HCC. Quantitative real-time polymerase chain reaction and immunohistochemistry were used to confirm SLC39A10 expression. Intro studies were performed to assess the effects of SLC39A10 on HCC cells proliferation and migration. Furthermore, flow cytometry was conducted to identify its specific function in apoptosis of HCC. @@@ Results: SLC39A10 was significantly over-expressed in HCC samples from both bioinformatic databases and our cohort. Survival analyses suggested patients with high expression of SLC39A10 had poor overall survival and disease-free survival (P-value <0.01). Further, the expression of SLC39A10 was positively correlated with tumor-infiltrating lymphocytes and some immune checkpoints like CTLA4, TIM3 and TGFB1. In HCC cell lines, SLC39A10 knockdown inhibited cells proliferation and migration, but promoted apoptosis. @@@ Conclusion: An increased SLC39A10 expression was found and served as an unfavorable indicator of survival in HCC. Further studies suggested SLC39A10 promotes tumor aggressiveness and may provide a novel target for HCC therapy.

学科与关键词

关键词
Solute Carrier Family 39 Member 10hepatocellular carcinomaimmune infiltrationprognosiscancer aggressiveness
相关
加载中…
  • A prospective diagnostic and prognostic biomarker for hepatocellular carcinoma that functions in glucose metabolism regulation: Solute carrier family 37 member 3
    Meng, Ziyu; Geng, Xue; Lin, Xiaoyue; Wang, Ziwei; Chen, Danchun; Liang, Hua; Zhu, Ying; Sui, Yutong*Biochimica et Biophysica Acta - Molecular Basis of Disease, 2023, 1869(4): 166661.
  • A comprehensive computational analysis to explore the importance of SIGLECs in HCC biology
    Yao, Senbang; Chen, Wenjun; Chen, Tingting; Zuo, He; Bi, Ziran; Zhang, Xiuqing; Pang, Lulian; Jing, Yanyan; Yin, Xiangxiang; Cheng, Huaidong*BMC GASTROENTEROLOGY, 2023, 23(1): 42.被引 1
  • Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma
    Mai, Jialuo; Hua, Xuefeng; Bian, Zhen-Hua; Xia, Yu; Zhao, Zhi-Bin; Lu, Minqiang*Translational Cancer Research, 2022, 11(7): 2262-+.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Hepatocellular Carcinoma
发表日期
2021
卷期
第 8 卷
页码
899-912
DOI
10.2147/JHC.S320326
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Guangdong Provincial People's Hospital [2020bq09, 8200100290, KY012021164]; Basic and applied basic research funding of Guangdong Province [2020A1515110536, 2021A1515011473, 2021A1515012441, 2021A1515011577]; Science and Technology Program of Guangzhou [202102020030, 202102020107]; Science and Technology Program of Huizhou [2019C0602009]; Science and Technology Program of Huizhou Daya Bay [2020030401]; Construction of Key Specialty in Huizhou; National Natural Science Foundation of China [82072635, 82072637, 81672475]

作者

  • M

    Ma, Zuyi (第一作者)

    guangdong prov peoples hosp · shantou univ

  • L

    Li, Zhenchong

    guangdong prov peoples hosp

查看全部 13 位作者收起作者
  • W

    Wang, Shujie

    guangdong prov peoples hosp · 2 · southern med univ

  • Z

    Zhou, Qi

    1 · sun yat sen univ

  • M

    Ma, Zuguang

  • L

    Liu, Chunsheng

    guangdong prov peoples hosp · shantou univ

  • H

    Huang, Bowen

    chinese acad med sci · peking union med coll · peking union med coll hosp

  • Z

    Zheng, Zehao

    guangdong prov peoples hosp · shantou univ

  • Y

    Yang, LinLing

    guangzhou med univ

  • Z

    Zou, Yiping

    guangdong prov peoples hosp · shantou univ

  • Z

    Zhang, Chuanzhao

    guangdong prov peoples hosp · 2 · southern med univ

  • H

    Huang, Shanzhou (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

  • H

    Hou, Baohua (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417